Table 4.

Effect of SC-RP on the lifespan of daf-16 (mgDf50) mutants, age-1 (hx546) mutants, clk-1(e2519) mutants, mev-1(kn1) mutants, and skn-1(zu135) mutants (mean ± SD, n = 3).

Genotype and condition	Treatment	Means lifespan	Maximum lifespan	Number	Mean fold increase%/ Genetic requirementa
daf-16 (mgDf50) (20°C, Days)	0 μg/mL	15.56 ± 0.18	20.33 ± 0.71	147/150	yes
	10 μg/mL	15.84 ± 0.05	20.67 ± 0.58	150/150
age-1 (hx546) (20°C, Days)	0 μg/mL	22.98 ± 0.57	34.33 ± 1.15	150/150	-
	10 μg/mL	24.47 ± 0.56*	37.67 ± 0.54***	147/150	6.48
clk-1(e2519) (20°C, Days)	0 μg/mL	24.90 ± 0.06	34.00 ± 0.00	134/150	yes
	10 μg/mL	24.88 ± 0.12	32.33 ± 0.58*	147/150
mev-1(kn1) (20°C, Days)	0 μg/mL	14.89 ± 0.26	19.33 ± 0.58	145/150	-
	10 μg/mL	18.55 ± 0.56***	25.00 ± 1.00***	148/150	24.58
skn-1(zu135) (20°C, Days)	0 μg/mL	14.49 ± 0.72	21.00 ± 0.00	141/150	yes
	10 μg/mL	15.01 ± 0.50	20.67 ± 0.58	146/150

^* P < 0.05;

^***P < 0.001.

^aPercentage of mean fold increase is relative to the control.